慢性病患儿兄弟姐妹与父母团体干预(SIBS-RCT):随机对照试验研究方案
SIBS-RCT 是一项随机对照试验,比较针对神经发育障碍患儿兄弟姐妹(8–16 岁)及父母的五次团体干预与 12 周等待名单。主要结局为兄弟姐妹心理健康,次要结局为生活质量和家庭沟通;计划纳入 288 名兄弟姐妹及其父母。
要点
- 干预含三次兄弟姐妹与父母分别团体课程和两次亲子单独对话联合课程。
- 主要结局为兄弟姐妹心理健康,次要结局为生活质量和家庭沟通。
- 12 周后比较干预与等待名单差异,并做 3、6、12 个月随访。
核心结论
- SIBS-RCT 旨在为神经发育障碍患儿兄弟姐妹建立循证团体干预。
- 若干预与等待名单无差异,仍将识别有阳性反应的亚组和有效成分。
研究设计与样本
- 随机对照试验,比较五次手册化团体干预与 12 周等待名单。
- 对象为神经发育障碍患儿兄弟姐妹(8–16 岁)及其父母。
- 计划纳入 288 名兄弟姐妹及其父母,2022 年底完成招募。
- 通过挪威市政和专科健康中心招募,按六人一组区组随机。
主要发现
- 原文为研究方案,未报告干预效果数值。
关键数值与推荐
- 干预含三次兄弟姐妹与父母分别团体课程和两次亲子单独对话联合课程。
- 主要结局为兄弟姐妹心理健康,次要结局为生活质量和家庭沟通。
- 主要效应为干预后 12 周与等待名单的差异。
- 结局采用电子化收集,时点为基线、干预/等待后及干预后 3、6、12 个月。
临床怎么用
- 干预聚焦改善亲子沟通,涵盖兄弟姐妹对神经发育障碍的理解、情绪和家庭挑战。
- 研究者将检验团体领导者依从性作为结局预测因素,以迭代优化手册。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Siblings and parents of children with neurodevelopmental disorders are at risk of mental health problems and poorer family communication. Some group interventions for siblings exist, but few have clearly described parent components and none are considered evidence-based. METHODS: We are conducting a randomized controlled trial comparing a five-session manual-based group intervention for siblings (aged 8 to 16 years) and parents of children with neurodevelopmental disorders to a 12-week waitlist, called SIBS-RCT. The intervention comprises three separate sibling and parent group sessions and two joint sessions in which each sibling talks to their parent alone. The intervention aims at improving parent-child communication and covers themes such as siblings' understanding of the neurodevelopmental disorder, siblings' emotions, and perceived family challenges. Participants are recruited through municipal and specialist health centers across Norway. The primary outcome is sibling mental health. Quality of life and family communication are secondary outcomes. Participants are block-randomized to the intervention or 12-week waitlist in groups of six. Measures are collected electronically at pre- and post-intervention/waitlist, as well as 3, 6, and 12 months post-intervention. The main effect to be examined is the difference between the intervention and waitlist at 12 weeks post. All outcomes will also be examined using growth curve analyses. We plan to include 288 siblings and their parents by the end of 2022. DISCUSSION: SIBS-RCT represents a major contribution to the research and practice field towards establishing an evidence-based intervention for siblings. In the event that intervention and waitlist are no different, the impact of SIBS-RCT is still substantial in that we will aim to identify participant subgroups that show positive response and effective components of the SIBS manual by examining group leader adherence as an outcome predictor. This will allow us to continue to re-engineer the SIBS manual iteratively to improve outcomes, and avoid the promotion of a less-than-optimal intervention. TRIAL REGISTRATION: ClinicalTrials.gov NCT04056884 . Registered in August 2019.
引用
- Fjermestad KW, Silverman WK, Vatne TM, et al. Group intervention for siblings and parents of children with chronic disorders (SIBS-RCT): study protocol for a randomized controlled trial. Trials. 2020. PMID: 33054825. doi:10.1186/s13063-020-04781-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。